8-K

Company

CRESCENT BIOPHARMA, INC.

Filed

March 29, 2016

Period of Report

March 24, 2016

Accession Number

0001558370-16-004451

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →